Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein

Mostrar otras versiones (1)

INTRODUCTION: Despite the availability of several COVID-19 vaccines, the incidence of infections remains a serious issue. Tunicamycin (TM), an antibiotic, inhibited tumor growth, reduced coronavirus envelope glycoprotein subunit 2 synthesis, and decreased N-linked glycosylation of coronavirus glycop...

Descripción completa

Detalles Bibliográficos
Autor principal: Dawood, Ali Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633632/
https://www.ncbi.nlm.nih.gov/pubmed/36349218
http://dx.doi.org/10.1016/j.vacun.2022.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633632/
https://www.ncbi.nlm.nih.gov/pubmed/36349218
http://dx.doi.org/10.1016/j.vacun.2022.10.006

Ejemplares similares